Request an Appointment Online, or call us at (888) 824-0200

The University of Chicago Medicine - Comer Children's Hospital

Childhood Leukemia

Leukemia is the most common form of cancer seen in children, affecting more than 3,000 children in the United States each year. While a diagnosis of this illness seems overwhelming, there is cause to be optimistic. Important scientific breakthroughs in the treatment of leukemia are being made and tested here at the University of Chicago. Our pediatric cancer care team has the extensive experience needed to provide young leukemia patients outstanding clinical care -- offering both the latest investigational therapies as well as established treatments for all types of leukemia. In fact, the University of Chicago Medicine Comer Children's Hospital was the first hospital in Chicago certified to offer CAR T-cell gene therapy for the treatment of acute lymphoblastic leukemia (ALL) in children and young adults.

One Team -- Focused on Your Family

At Comer Children’s, our dynamic multidisciplinary team approach brings together years of clinical experience with cutting edge research, providing the best possible care for every child and teen. The team includes:

  • Nationally recognized physicians who write the new treatment protocols for this disease, and who have over 100 years of cumulative experience caring for children with leukemia.
  • Pathologists, radiation oncologists and radiologists who are national leaders in the development of new diagnostic and therapeutic strategies for leukemia.
  • Nurses who are trained specifically to care for this disease.
  • Child life specialists, social workers, psychologists and other care providers who work together tirelessly to care for children with leukemia.

Medical care is provided in a family-centered environment -- focused not only on the child, but also on the parents and siblings dealing with cancer in their family.

Specialized Care for Adolescents and Young Adults with Leukemia

Recognizing that patients ages 15 through 30 often have different personal, psychosocial and medical needs than younger children and older adults, the University of Chicago Medicine created the Adolescent and Young Adult (AYA) Oncology Program. Our team of adult and pediatric hematologists/oncologists optimizes care for young adults by developing individualized treatment plans, offering participation in national clinical trials, and providing support tailored to this unique population. We help adolescent patients and their families navigate the medical challenges and personal issues of a leukemia diagnosis.

Learn more about our program for adolescents and young adults with leukemia

Among the Top Cancer Programs in the Nation

Our pediatric cancer physicians and researchers are members of the world-famous University of Chicago Comprehensive Cancer Center, a NCI-designated Comprehensive Cancer Center -- a consortium of select centers leading the nation in cancer research and providing patients with more effective health care. These teams of researchers work collaboratively, across scientific disciplines, to explore and develop innovative ways to fight and cure cancer. Because of our high level of expertise and access to the latest therapies, patients from the Midwest, the nation and around the world come to our cancer program for treatment.